HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

Renaloo a leading patient organisation in kidney diseases, dedicated to transforming the lives of people with kidney conditions

Administrator at RENALOO

Paris, France

About

Renaloo is a French patient association dedicated to chronic kidney disease, dialysis, and transplantation.

We strongly believe that the needs of kidney patients could provide a strong case to explore issues such as 
- Co-design the renal use cases, particularly for dialysis, post-transplant follow-up, and palliative care phases;
- Contribute to real-life validation with patients and caregivers;
- Provide expertise in acceptability, ethics, communication, and patient empowerment;
- Disseminate the results through its French and European networks (authorities, alliances, platforms, etc.).

Potential Contribution of Renaloo

Co-creation
Patient workshops, focus groups on specific CKD needs Real-life, patient-centered approach

Ethics & Governance     

Participation in steering committees, review of protocols   
Strengthening societal legitimacy

Communication & Dissemination
Production of accessible materials, awareness among associations and media    

Visibility of the project in France and across Europe

Field Validation  

Prototype testing with dialysis and transplant patients     

Concrete data on usability and acceptability.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Organisation

RENALOO

Association/Agency/Cluster

PARIS, France

Similar opportunities

  • Project cooperation

    KIDNEYs FIRST EU- From First Risk Signal to First Clinical Action in Chronic Kidney Disease

    • Consortium/Coordinator seeks Partners
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Ahmet Murt

    Associate Professor at ISTANBUL UNIVERSITY-CERRAHPASA

    Istanbul, Türkiye

  • Project cooperation

    Climate, Kidneys, and Cognition: Establishing Causal Pathways from Climate Stressors to NCD Progression

    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health

    Shazia Adalat

    Chair, Climate-Kidneys-Cognition Working Group at Climate-Kidneys-Cognition Working Group

    London, United Kingdom

  • Project cooperation

    In vivo CRISPR-mRNA Cas9 for KO in CD34 HSPCs

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health

    Oren Glanz

    Co-founder and CEO at Lempo Therapeutics

    Binyamina, Israel